Remo Panaccione

Director, Inflammatory Bowel disease Unit, Professor of Medicine

University of Calgary

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Vivian Huang

Assistant Professor and Clinician Investigator

University of Toronto

CANADA

View details

Subrata Ghosh

University of Birmingham

UNITED KINGDOM

View details

Séverine Vermeire

University Hospitals Leuven

BELGIUM

View details

James East

University of Oxford

UNITED KINGDOM

View details

Simon P L Travis

UNITED KINGDOM

View details

David Rubin

Professor

University of Chicago

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Remo Panaccione

Research Interests

Explore related searches

Contact this professor

Articles (10)

Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study

Efficacy and safety of approximately 3 years of continuous ozanimod in moderately to severely active ulcerative colitis: interim analysis of the True North open-label extension

Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions

Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis

Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis

Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open

Review article: therapeutic targets for the pharmacologic management of coeliac disease—the future beyond a gluten‐free diet

Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials

Collaborators (6)

Vivian Huang

Subrata Ghosh

Séverine Vermeire

James East

Simon P L Travis

David Rubin

Make your next move.